Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-6950 Phase I Single-dose Oral Study in Healthy Japanese Male Adults
jRCT2080221411Phase 1
- Sponsor
- Ono Pharmaceutical
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in allergy comparing ONO-6950 with Placebo (2 arms).
02
Drugs
gemilukast
03
Conditions
allergy
Beyond the preview
Go deeper on jRCT2080221411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221411.